The invention relates to pyrazolyl-based carboxamide compounds useful as ICRAC inhibitors, to pharmaceutical compositions containing these compounds and to these compounds for the use in the treatment and/or prophylaxis of diseases and/or disorders, in particular inflammatory diseases and/or inflammatory disorders.
本发明涉及以
吡唑基为基础的羧酰胺化合物,其作为ICRAC
抑制剂有用,涉及含有这些化合物的制药组合物,以及这些化合物在治疗和/或预防疾病和/或紊乱,特别是炎症性疾病和/或炎症性紊乱方面的用途。